Swissmedic approves "Ronapreve(R)" for COVID-19 patients
31. Dezember 2021 – Swissmedic has approved the medicinal product Ronapreve, which was already authorised for prescription in Switzerland under COVID-19 Ordinance 3. Ronapreve is an antibody combination that can be used for treatment or prevention of coronavirus disease.
For more information see here.